Compared with normal controls, BPH patients exhibited higher expression levels of FGF2 (Figure 6K, P < 0.001) and BDNF (Figure 6O, P < 0.001) in the serum. This evidence concerns the gene FGF2 and benign prostatic hyperplasia.